
Relugolix is an oral hormone therapy used to treat advanced prostate cancer by reducing testosterone production. Lowering testosterone can slow the growth of prostate cancer cells that depend on this hormone for survival and multiplication.
| Generic Name | Relugolix |
| Strength | 120 mg |
| Manufacturer | Zydus |
| Packing | 30 Tablets |
| Prescribed For | Advanced prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Relugolix blocks gonadotropin-releasing hormone receptors in the pituitary gland. This reduces the production of hormones that instruct the testicles to make testosterone. Lower testosterone levels can slow the growth of prostate cancer that depends on this hormone.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.